EBioMedicine · 2019 · 72 citations · 29 references
MedicineCancer BiologyOncologyCell SignalingMolecular OncologySignal TransductionCancer BiomarkersCancer Cell SignalingCancer MetabolismFatty Acid MetabolismMetabolic Reprogramming In CancerSignal Transduction In CancerAbc TransportersBreast Cancer Resistance MechanismsFatty AcidsG Protein-coupled Receptor RegulationIntracellular Drug AccumulationLong-chain Polyunsaturated Fatty AcidsPi3k-akt Signaling PathwayUnsaturated Fatty Acids
BACKGROUND: Chemoresistance is the major cause of neoadjuvant treatment failure in breast cancer patients. Despite recent progress, the mechanism underlying chemoresistance remains to be further defined. METHODS: Expression of G protein-coupled receptor 120 (GPR120) was analyzed by immunohistochemistry in the biopsies of primary breast cancer who subsequently underwent preoperative neoadjuvant chemotherapy. In vitro and in vivo loss- and gain-of -function studies were performed to reveal the effects and related mechanism of GPR120 signaling pathway in the chemoresistance of breast cancer cells. FINDINGS: We identified that GPR120, a receptor for long-chain fatty acids, was important for the acquisition of chemoresistance in breast cancer cells. We showed that GPR120 expression was positively associated with clinical response to neoadjuvant chemotherapy in patients. In breast cancer cells, GPR120 enhanced the de novo synthesis of fatty acids that served as GPR120 ligands to activate GPR120 signaling via a feedback mechanism. Upregulated GPR120 signaling rendered cells resistant to epirubicin-induced cell death by upregulating ABC transporters expression and thus decreasing the intracellular accumulation of epirubicin. Akt/NF-κB pathway was responsible for the GPR120-mediated expression of ABC transporters leading to modulation of the concentration of chemotherapeutic drugs in cells. The functional importance of GPR120 in chemoresistance was further validated using epirubicin-treated tumor xenografts, in which we showed that blockade of GPR120 signaling with AH7614 or GPR120-siRNA significantly compromised chemoresistance. INTERPRETATION: Our results highlight that GPR120 might be a promising therapeutic target for breast cancer chemoresistance. FUND: National Natural Science Foundation of China, Ministry of Science and Technology of China, Program of Science and Technology Commission of Shanghai Municipality.
29
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120
Akira Hirasawa, Keiko Tsumaya, Takeo Awaji et al. · Nature Medicine · 2004 · 1.5K citations
Robert Pirker, Jose R. Pereira, Joachim von Pawel et al. · The Lancet Oncology · 2011 · 574 citations
Medicine, Oncology, Pharmacology +17
A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice
Da Young Oh, Evelyn Walenta, Taro E. Akiyama et al. · Nature Medicine · 2014 · 389 citations · Full text